Authors:
Di Marco, R
Puglisi, G
Papaccio, G
Nicoletti, A
Patti, F
Reggio, A
Bendtzen, K
Nicoletti, F
Citation: R. Di Marco et al., Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat, MULT SCLER, 7(2), 2001, pp. 101-104
Authors:
Patti, F
Cataldi, ML
Nicoletti, F
Reggio, E
Nicoletti, A
Reggio, A
Citation: F. Patti et al., Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis, J NE NE PSY, 71(3), 2001, pp. 404-407
Authors:
Nicoletti, F
Di Marco, R
Patti, F
Zaccone, P
L'Episcopo, MR
Reggio, E
Xiang, M
Nicoletti, A
Reggio, A
Citation: F. Nicoletti et al., Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)beta 1b transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1 beta, IL-2, IL-4 and tumour necrosis factor-alpha, CYTOKINE, 12(6), 2000, pp. 682-687
Authors:
Nicoletti, F
Di Marco, R
Patti, F
Nicoletti, A
Leonardi, C
Reggio, E
Meroni, P
Reggio, A
Citation: F. Nicoletti et al., The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells, AUTOIMMUN, 32(4), 2000, pp. 265-270
Authors:
Patti, F
L'Episcopo, MR
Cataldi, ML
Reggio, A
Citation: F. Patti et al., Natural interferon-beta treatment of relapsing-remitting and secondary-progressive multiple sclerosis patients. A two-year study, ACT NEUR SC, 100(5), 1999, pp. 283-289